You are here
Home 🌿 Cannabis Technology News 🌿 Study Finds Marijuana Often Used to Treat Symptoms of Chronic Pain, Anxiety and Insomnia 🌿Study Finds Marijuana Often Used to Treat Symptoms of Chronic Pain, Anxiety and Insomnia
Warning message
The subscription service is currently unavailable. Please try again later.According to a new study, those who use marijuana for therapeutic purposes are more likely to report consuming it to address symptoms such as anxiety, insomnia, chronic pain and depression. The study, titled Medical reasons for marijuana use, forms of use, and patient perception of physician attitudes among the US population,” was published in the Journal of General Internal Medicine and first reported on by NORML.
For the study researchers examined responses from a nationally represented online sample of adults. “Among those who acknowledged using cannabis for medical purposes, 49 percent reported doing so to treat anxiety. Forty-seven percent of respondents said that they used cannabis for insomnia, 42 percent said that they did so to treat chronic pain, and 39 percent said that cannabis eased their depression.”
The most preferred method of consumption was through inhalation, “Women, more frequently than men, reported using cannabis to address symptoms of post-traumatic stress, insomnia, anxiety, and migraines. Men were more likely to report using cannabis as a mood stabilizer.”
Of those respondents who had disclosed their medical cannabis use to their primary care physician, nearly half said that their doctor was supportive of their decision.
The full abstract of the study can be found below:
BACKGROUND:
The use of marijuana for medical purposes is increasing in parallel with expanding legalization and decreased public perception of harm. Despite this increase in use, it is unclear which medical conditions patients are attempting to treat with marijuana and whether they are communicating with medical providers about their use.
OBJECTIVE:
To understand the medical reasons for marijuana use, forms of marijuana used for medical purposes, and disclosure of use to physicians.
DESIGN:
National, probability-based online survey.
SETTING:
The USA, 2017.
PARTICIPANTS:
16,280 US adults.
MAIN MEASURE:
Proportion of US adults who agreed with a statement.
KEY RESULTS:
A total of 9003 participants completed the survey (55% response rate). Five hundred ninety-one (7% of US adults) reported using marijuana for medical purposes. The most common medical reasons for marijuana use were anxiety (49%), insomnia (47%), chronic pain (42%), and depression (39%). The most common forms of use for all medical conditions were smoking and edibles, followed by vaping, concentrate, and topical. We found women were more likely to use marijuana for posttraumatic stress disorder, sleep, anxiety, and migraines. We did not find substantial variation in medical reasons for marijuana use by race. Among those using marijuana for medical purposes, 21% did not have a doctor. Among those with doctors, 33% did not inform them, 28% reported their doctor was neutral on their use, 32% reported their doctor was supportive, and 8% reported their doctor was not supportive. Those who lived in states where medical marijuana was illegal were less likely to disclose use to their doctor.
LIMITATION:
The online format of the survey may have caused selection bias. Wording of the questions may have affected interpretation. Doctors were not queried directly, rather participants were asked about their perception of doctor attitudes.
CONCLUSION:
Americans are using marijuana to treat medical conditions despite lack of evidence of efficacy.
The list of researchers involved in the study can be found below:
- Department of Internal Medicine, University of California, San Francisco, San Francisco, CA, USA. pazcarate@ucsd.edu.
- Division of General Internal Medicine, University of California San Francisco, San Francisco, CA, USA. pazcarate@ucsd.edu.
- Cardiovascular Medicine, University of California San Diego, San Diego, USA. pazcarate@ucsd.edu.
- Northern California Institute for Education and Research, San Francisco VA Medical Center, San Francisco, CA, USA.
- Department of Medicine, UCSF Division of General Internal Medicine, San Francisco VA Medical Center, San Francisco, CA, USA.
- San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
- Department of Internal Medicine, University of California, San Francisco, San Francisco, CA, USA.
- Department of Medicine, UCSF Division of Nephrology, San Francisco VA Medical Center, San Francisco, CA, USA.
- Department of Nephrology, University of California, San Francisco, San Francisco, CA, USA.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.